A nurse is caring for a client with major depressive disorder who has been prescribed sertraline (Zoloft) 50 mg daily. The client reports feeling "much better" after 5 days of treatment and asks to discontinue the medication. What is the most appropriate nursing response?

Antidepressants like sertraline require 4-6 weeks for full effect; early discontinuation risks relapse. The nurse must educate on compliance and therapeutic timeline.

Therapeutic Response Timeline for SSRIs

The client's perception of improvement after only 5 days reflects an initial physiological response, not the full therapeutic effect required for sustained remission. Sertraline, a selective serotonin reuptake inhibitor (SSRI), begins blocking the reuptake of serotonin at the synaptic cleft shortly after administration. However, the clinical antidepressant effect relies on downstream neuroplastic changes, including the desensitization of presynaptic autoreceptors and the upregulation of postsynaptic receptors, a process that takes significantly longer . This explains the well-established clinical guideline that antidepressants require 4 to 6 weeks to achieve their full therapeutic potential. Premature discontinuation based on early, often placebo-related or transient mood elevation, places the client at high risk for relapse and incomplete recovery.

Risk of Abrupt Discontinuation

Supporting the client's decision to stop the medication abruptly is contraindicated due to the risk of a well-documented physiological phenomenon. Abrupt cessation of SSRIs can precipitate a withdrawal syndrome, characterized by sensory disturbances, disequilibrium, and flu-like symptoms, which can be mistaken for a recurrence of the depressive episode ^[1]. This physiological dependence is distinct from addiction and requires clinical management. The decision to discontinue an antidepressant should only be considered when the recommended duration of therapy is complete and there is no clinical indication for continued use, or when adverse effects definitively outweigh therapeutic benefits ^[1]. A subjective feeling of being "much better" after 5 days does not meet either criterion.

Medication Adherence and Shared Decision-Making

Non-adherence is a significant barrier to achieving remission in major depressive disorder, often driven by a lack of understanding regarding the treatment timeline and medication necessity . The most appropriate nursing action is to provide psychoeducation that bridges the gap between the client's subjective experience and the pharmacological reality. While the client's ultimate decision-making authority is respected, the nurse's role is to explain the mechanism of action, correct misconceptions about the speed of recovery, and emphasize the importance of continuing the medication as prescribed to prevent relapse. Recommending a dose reduction or advising a consultation without first providing essential education fails to address the core knowledge deficit driving the request. The nurse must first reinforce the treatment rationale, explaining that the current dose is a standard therapeutic starting point and that altering the regimen without a full therapeutic trial undermines the treatment's purpose and increases the risk of a prolonged or recurrent depressive episode ^[1].